UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

Clinical cancer research, 2007-12, Vol.13 (23), p.7003-7011

2007

Volltextzugriff (PDF)

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

Journal of clinical oncology, 2006-01, Vol.24 (2), p.268-273

2006

Volltextzugriff (PDF)

Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis

PloS one, 2009-03, Vol.4 (3), p.e4687

2009

Volltextzugriff (PDF)

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer

Scientific reports, 2023-10, Vol.13 (1), p.17949-17949, Article 17949

2023

Volltextzugriff (PDF)

Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1

Cancer discovery, 2013-05, Vol.3 (5), p.578-589

2013

Volltextzugriff (PDF)

Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer

Cancer research (Chicago, Ill.), 2009-06, Vol.69 (11), p.4708-4715

2009

Volltextzugriff (PDF)

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

The journal of pathology. Clinical research, 2019-10, Vol.5 (4), p.272-286

2019

Volltextzugriff (PDF)

The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients

The journal of pathology. Clinical research, 2021-05, Vol.7 (3), p.253-270

2021

Volltextzugriff (PDF)

Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1

Proceedings of the National Academy of Sciences - PNAS, 2009-07, Vol.106 (29), p.12115-12120

2009

Volltextzugriff (PDF)

Combined Loss of PTEN and p27 Expression Is Associated with Tumor Cell Proliferation by Ki-67 and Increased Risk of Recurrent Disease in Localized Prostate Cancer

Clinical cancer research, 2003-04, Vol.9 (4), p.1474-1479

2003

Volltextzugriff (PDF)

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival

The Journal of urology, 2009-11, Vol.182 (5), p.2144-2149

2009

Volltextzugriff (PDF)

Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer

Virchows Archiv : an international journal of pathology, 2006-01, Vol.448 (1), p.68-74

2006

Volltextzugriff (PDF)

A positive real‐time elastography is an independent marker for detection of high‐risk prostate cancers in the primary biopsy setting

BJU international, 2014-05, Vol.113 (5b), p.E90-E97

2014

Volltextzugriff (PDF)

The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy

BMC urology, 2008-12, Vol.8 (1), p.19-19, Article 19

2008

Volltextzugriff (PDF)

A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy

BMC urology, 2016-07, Vol.16 (1), p.39-39, Article 39

2016

Volltextzugriff (PDF)

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-08, Vol.117 (8), p.575-582

2009

Volltextzugriff (PDF)

Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort

Scandinavian journal of urology, 2015-02, Vol.49 (1), p.8-15

2015

Volltextzugriff (PDF)

Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers

Scandinavian journal of urology, 2013-06, Vol.47 (3), p.211-216

2013

Volltextzugriff (PDF)

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers

Cancer research (Chicago, Ill.), 2002-12, Vol.62 (23), p.6808-6811

2002

Volltextzugriff (PDF)

Is preoperative serum prostate‐specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?

BJU international, 2006-01, Vol.97 (1), p.51-55

2006

Volltextzugriff (PDF)

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen‐deprivation therapy for hormone‐naïve bone‐metastatic prostate cancer

BJU international, 2018-10, Vol.122 (4), p.583-591

2018

Volltextzugriff (PDF)

A positive Real-Time Elastography score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy

BMC urology, 2016-07, Vol.16 (1)

2016

Volltextzugriff (PDF)

Augmentation of natural killer cell activity after arterial embolization of renal carcinomas

Cancer research (Chicago, Ill.), 1982-09, Vol.42 (9), p.3880-3883

1982

Volltextzugriff (PDF)

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Scandinavian journal of urology and nephrology, 2008, Vol.42 (3), p.220-229

2008

Volltextzugriff (PDF)

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Scandinavian journal of urology and nephrology, 2011-11, Vol.45 (5), p.346-353

2011

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast

Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer

Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1

Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients

Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1

Combined Loss of PTEN and p27 Expression Is Associated with Tumor Cell Proliferation by Ki-67 and Increased Risk of Recurrent Disease in Localized Prostate Cancer

The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival

Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer

A positive real‐time elastography is an independent marker for detection of high‐risk prostate cancers in the primary biopsy setting

The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy

A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis

Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort

Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers

Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers

Is preoperative serum prostate‐specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?

Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen‐deprivation therapy for hormone‐naïve bone‐metastatic prostate cancer

A positive Real-Time Elastography score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy

Augmentation of natural killer cell activity after arterial embolization of renal carcinomas

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

Suchergebnisse filtern